Tukysa is a targeted oral anticancer medication containing Tucatinib, used in the treatment of certain HER2-positive breast cancers, particularly advanced or metastatic cases. It works by blocking signals that promote cancer cell growth, helping slow disease progression.
Indications
-
Treatment of advanced or metastatic HER2-positive breast cancer
-
Used in combination with other targeted therapies
-
Helps slow tumor growth and spread
-
Supports disease control
Directions for Use
Take orally as prescribed by a healthcare professional, typically twice daily as part of a treatment regimen.
Warnings
-
Prescription medicine – use under medical supervision
-
May cause diarrhea or liver function changes
-
Regular laboratory monitoring is required
-
Not recommended during pregnancy
-
Keep out of reach of children
Reviews
There are no reviews yet.